Attached files
| file | filename |
|---|---|
| EX-31.2 - EX-31.2 - Ampio Pharmaceuticals, Inc. | d63069dex312.htm |
| 10-K - FORM 10-K - Ampio Pharmaceuticals, Inc. | d63069d10k.htm |
| EX-32.1 - EX-32.1 - Ampio Pharmaceuticals, Inc. | d63069dex321.htm |
| EX-31.1 - EX-31.1 - Ampio Pharmaceuticals, Inc. | d63069dex311.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in Registration Statements on Forms S-8 Nos. 333-186077, 333-181626, 333-175161, and 333-194428 and Form S-3 No. 333-193096 of Ampio Pharmaceuticals, Inc. and Subsidiaries of our report dated February 26, 2016 relating to our audit of the consolidated financial statements and internal control over financial reporting of Ampio Pharmaceuticals, Inc. and Subsidiaries, which appears in this Annual Report on Form 10-K of Ampio Pharmaceuticals, Inc. and Subsidiaries as of and for the year ended December 31, 2015.
EKS&H LLLP
February 26, 2016
Denver, Colorado